Search This Blog

Tuesday, December 26, 2023

Coherus: FDA OKs UDENYCA ONBODY Cancer Therapy Delivery System

  Innovative design enables five-minute pegfilgrastim delivery time 

 Unique, automatic, retractable needle mechanism engineered to maximize safety and comfort for cancer patients receiving pegfilgrastim 

https://www.globenewswire.com/news-release/2023/12/26/2801155/33333/en/Coherus-Announces-FDA-Approval-of-UDENYCA-ONBODY-a-Novel-and-Proprietary-State-of-the-Art-Delivery-System-for-pegfilgrastim-cbqv.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.